New genetically engineered vaccines target Rift Valley fever

This is a scene from a Rift Valley cattle market. A new vaccine may help both cattle and people avoid the Rift Valley fever. Credit: Tilahun Yilma/UC Davis

(PhysOrg.com) -- Researchers from the University of California, Davis, and elsewhere are reporting the development of two genetically engineered vaccines to combat the mosquito-borne Rift Valley fever, devastating to livestock and so far confined to Africa and the Middle East.

The virus can sicken people, too, who can be infected by or by direct contact with infected animals or their meat.

The scientists from UC Davis, the University of Connecticut and the University of Texas Medical Branch hope the new vaccines can be further developed for use in people.

The is the subject of a paper that was posted this week in the online edition of the scientific journal .

“There currently are no approved vaccines available for treating Rift Valley fever in humans, and those available for livestock are either inefficient or have serious side effects,” said lead author Tilahun Yilma, a veterinary professor specializing in viral diseases and the director of the International Laboratory of Molecular Biology for Tropical Diseases in the UC Davis School of Veterinary Medicine.

“Because Rift Valley fever is spread by mosquitoes, there is concern that the disease could be accidentally or intentionally introduced to North America and other regions where it is not now found,” he said. “Such an introduction could have devastating economic and human health implications.”

Earlier in his career, Yilma did extensive work on foot-and-mouth disease and developed a similar for the devastating cattle disease rinderpest, which the World Organisation for Animal Health in May declared to be eradicated.

About Rift Valley Fever

Rift Valley fever is a viral disease first identified in 1931 among sheep in the Rift Valley of Kenya. Since then, outbreaks have been reported in Sub-Saharan and North Africa, and there was a major outbreak of the disease in 1998-99 in Kenya, Somalia and Tanzania.

In 2000, cases of Rift Valley fever were reported in Saudi Arabia and Yemen, the first reports of the disease outside of the African continent. This raised concern among health officials that the disease might spread to Asia, Europe and the Americas.

In livestock, the disease causes major losses due to illness, with the rate of abortion among pregnant sheep approaching 100 percent. In people, infection results in fever, hepatitis, vision loss and occasionally hemorrhagic fever.

About the new vaccines

In developing the two vaccines, the researchers made use of the vaccinia virus, the same virus used to make the smallpox vaccine. They inactivated two vaccinia genes to weaken that virus and prevent it from causing disease, and inserted two Rift Valley fever genes to stimulate an immune response, thereby equipping the vaccinated animals to fight off infection.

The vaccines are similar, except that one of them includes one more gene to further weaken the vaccinia virus and enhance the safety of the vaccine, especially for people who would be vaccinating livestock.

Both vaccines proved safe and produced significant immune responses when tested in mice and baboons, the researchers reported. When mice were challenged with the virus, the vaccines proved to be 90 percent protective.

In describing the advantages of the new vaccines, Yilma noted that both would be easy to produce in large scale and would not need to be refrigerated.

The researchers plan to conduct additional studies to determine how safe and effective the vaccines are in sheep and cattle.

Related Stories

Virus death toll rises in Kenya

Jan 26, 2007

Officials in Kenya are trying to stop the spread of Rift Valley Fever, which has killed at least 148 people.

Researchers examine role of climate change in disease spread

Feb 05, 2009

GALVESTON, Texas — Ever since scientists first proposed that our planet might be experiencing widespread climate change, concerns have been raised about its implications for the spread of arboviruses - viruses carried by ...

Climate change amplifying animal disease

May 25, 2009

Climate change is widening viral disease among farm animals, expanding the spread of some microbes that are also a known risk to humans, the world's top agency for animal health said on Monday.

Recommended for you

US hunts contacts of seriously ill Ebola patient

22 minutes ago

US health officials scoured the Dallas area Wednesday for people—including schoolchildren—who came in contact with a Liberian man who was diagnosed with Ebola, as it emerged a hospital mix-up saw him initially turned ...

Australia lifts Ebola donation to $16 million

32 minutes ago

Australia more than doubled its donation to the fight against Ebola in West Africa to 18 million Australian dollars ($16 million) on Thursday, but resisted demands to send personnel.

UN says Syria vaccine deaths was an NGO 'mistake'

12 hours ago

The recent deaths of Syrian children after receiving measles vaccinations was the result of a "mistake" by a non-governmental partner who mixed in a muscle relaxant meant for anesthesia, a spokesman for the U.N. secretary-general ...

First US child dies from enterovirus D68

13 hours ago

A child in the northeastern US state of Rhode Island has become the first to die from an ongoing outbreak of a respiratory virus, enterovirus D68, health officials said Wednesday.

User comments